- Neoadjuvant hepatic arterial infusion chemotherapy with FOLFOX could improve outcomes of resectable BCLC stage A/B hepatocellular carcinoma patients beyond Milan criteria: A multi-center, phase 3, randomized, controlled clinical trialWei, Wei; Li, Shaohua; Zhao, Rongce; Cheng, Yuan; Li, Qiang; Lu, Lianghe; Mei, Jie; Shang, Changzhen; Luo, Rui; Pan, Mingxin; Xiang, Bangde; Jiang, Yuchuan; Lei, Qiucheng; Cao, Mingrong; Li, Ji-Bin; Zheng, Lie; Chen, Huanwei; Zhong, Jian-Hong; Zhong, Chong; Guo, RongpingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 2
- Comparison of liver injury after transcatheter arterial chemoembolization and hepatic arterial infusion chemotherapy for intermediate and advanced hepatocellular carcinomaLi, R.; Li, W.; Yuan, G.; Li, Q.; Hu, X.; Zhu, P.; Chen, Y.; Su, K.; Guo, Y.; Zang, M.; Chen, J.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
- Lenvatinib in combination with PD-1 inhibitor and hepatic arterial infusion chemotherapy (HAIC) for patients with potentially resectable hepatocellular carcinoma: A retrospective analysis.Dong, Wei; Zhang, Songyan; Huo, Zhuoni; Lu, Junrong; Liu, Haishi; Wang, Ping; Zhang, YubaoAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
会议论文
Hepatic arterial infusion chemotherapy with oxaliplatin plus raltitrexed versus oxaliplatin plus fluorouracil in intermediate and advanced hepatocellular carcinoma: A retrospective study.
1被引11阅读
